Literature DB >> 32579014

Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19.

Klaus Mönkemüller1, Lucia C Fry2, Steffen Rickes3.   

Abstract

We thank Dr. Cienfuegos and colleagues for their comments on our recent publication "COVID-19, Coronavirus, SARS-CoV-2 and the small bowel". Cienfuegos et al. have treated several COVID-19 patients with thromboembolic complications, including bowel ischemia. The authors correctly highlight the importance of this complication in COVID-19 patients, which has also been documented in autopsy studies.

Entities:  

Mesh：

Year:  2020        PMID： 32579014     DOI： 10.17235/reed.2020.7297/2020

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


  4 in total

Review 1.  Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics.

Authors:  Yuan-Pin Hung; Ching-Chi Lee; Jen-Chieh Lee; Pei-Jane Tsai; Wen-Chien Ko
Journal:  Microorganisms       Date:  2021-07-28

Review 2.  Impact of COVID-19 on the Intestinal Microbiome.

Authors:  Carla Venegas-Borsellino; Senthilkumar Sankararaman; Keelin Roche; JBracken Burns; Ryan Michael Landis
Journal:  Curr Nutr Rep       Date:  2021-11-23

Review 3.  Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2.

Authors:  Alessandra Cenci; Iole Macchia; Valentina La Sorsa; Clemente Sbarigia; Valentina Di Donna; Donatella Pietraforte
Journal:  Front Microbiol       Date:  2022-04-21       Impact factor: 6.064

Review 4.  SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer.

Authors:  Mark C Howell; Ryan Green; Andrew R McGill; Rinku Dutta; Subhra Mohapatra; Shyam S Mohapatra
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.